Orange Book product · Brand (NDA)
LUMIFY PRESERVATIVE FREE
BRIMONIDINE TARTRATE
At a glance
Apr 19, 2024
Approved
Brand (NDA)
Application
Not listed
TE code
3
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 19, 2024
2 yr 2 mo ago
Today
Patent 11596600 expires
Listed method-of-use patent (U-2222) expiration.
Jul 27, 2029
in 3 yr 2 mo
Patent 8293742 expires
Listed method-of-use patent (U-2222) expiration.
Jul 14, 2030
in 4 yr 2 mo
Patent 9259425 expires
Listed method-of-use patent (U-2222) expiration.
Jul 14, 2030
in 4 yr 2 mo
Pharmaceutical detail
Active ingredient
BRIMONIDINE TARTRATE
Strength
0.025%
Dosage form
SOLUTION/DROPS
Route
OPHTHALMIC
TE code
Not listed
Application
NDA 218424
Product number
001
Marketing status
OTC
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2017LUMIFYBrand (NDA)
NDA 208144 · BAUSCH AND LOMB INC
- 2013MIRVASOBrand (NDA)
NDA 204708 · GALDERMA LABS LP
- 2006QOLIANABrand (NDA)
NDA 021764 · SANDOZ
- 2005ALPHAGAN PBrand (NDA)
NDA 021770 · ABBVIE
- 2001ALPHAGAN PBrand (NDA)
NDA 021262 · ABBVIE
- 1997ALPHAGANBrand (NDA)
NDA 020490 · ALLERGAN
- 1996ALPHAGANBrand (NDA)
NDA 020613 · ALLERGAN
- 2026BRIMONIDINE TARTRATEGeneric (ANDA)
ANDA 218558 · MICRO LABS
- 2026BRIMONIDINE TARTRATEGeneric (ANDA)
ANDA 220398 · MANKIND PHARMA
- 2026BRIMONIDINE TARTRATEGeneric (ANDA)
ANDA 219219 · GLAND
- 2025BRIMONIDINE TARTRATEGeneric (ANDA)
ANDA 217599 · UPSHER SMITH LABS
- 2024BRIMONIDINE TARTRATEGeneric (ANDA)
ANDA 213215 · LUPIN
Listed patents (3)
| Patent | Expires | In | Type |
|---|---|---|---|
| 11596600 | Jul 27, 2029 | in 3 yr 2 mo | U-2222 |
| 8293742 | Jul 14, 2030 | in 4 yr 2 mo | U-2222 |
| 9259425 | Jul 14, 2030 | in 4 yr 2 mo | U-2222 |

